What is the Fiscal Year for Opthea?
Date: November 13, 2026
Opthea's current fiscal year starts on July 1, 2026, and ends on June 30, 2027. Their current quarter is Q2, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
July 1, 2026
Fiscal Year End
June 30, 2027
Current Quarter
Q2
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jul 1, 2026 – Sep 30, 2026
Q2
Oct 1, 2026 – Dec 31, 2026
Q3
Jan 1, 2027 – Mar 31, 2027
Q4
Apr 1, 2027 – Jun 30, 2027
Company Information
Headquarters
South Yarra, VIC
Industry
Biotechnology Research
Stock Symbol
OPT
Website
http://www.opthea.com/Description
Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age‐related macular degeneration (wet AMD) and diabetic macular edema (DME), which remain leading causes of vision loss worldwide. Opthea’s lead product candidate in Phase 3 development, sozinibercept, is a first-in-class VEGF-C/D ‘trap’ inhibitor being evaluated in combination with standard-of-care anti-VEGF-A therapies to deliver superior vision to wet AMD patients. Sozinibercept has the potential to become the first therapy in 20 years to enable patients with wet AMD to live fuller and healthier lives.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Opthea and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.